# clm_9ED86C910D2E

subject: Abbott Laboratories (/record/abbott-laboratories.md)  
predicate: quarterly_research_and_development  
value: 715,000,000 United States dollar  
valid_from: 2023-06-30  
valid_to: 2023-09-30  
published: 2023-08-03  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_F557BBEDA577  
last_updated: 2026-11-08  
cite: AsOf. "Abbott Laboratories quarterly research and development: 715,000,000 United States dollar", as of 2023-06-30 (until 2023-09-30). Claim clm_9ED86C910D2E, https://asof.is/claim/clm_9ED86C910D2E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1800/000162828023027203/0001628280-23-027203-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2023, filed 2023-08-03  

## Sources

- https://www.sec.gov/Archives/edgar/data/1800/000162828023027203/0001628280-23-027203-index.htm (primary, SEC EDGAR 10-Q Q2 FY2023, published 2023-08-03)

## Supersedes

- [Abbott Laboratories](/record/abbott-laboratories.md) | quarterly_research_and_development | 654,000,000 United States dollar | valid 2023-03-31 to 2023-06-30 | conf 0.95 | superseded | superseded_by [clm_9ED86C910D2E](/claim/clm_9ED86C910D2E.md) | [clm_602C8D08E319](/claim/clm_602C8D08E319.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.